Italy withdraws its controversial bill to ban cultivated meat... for now!

Plus, UMIAMI scoops US$34.7 million to drive plant-based chicken, Harvard study proves negative effect of red meat on diabetes, and more

Welcome to this week's instalment of must-read stories from the world of alternative proteins. Once again, a nice blend of tech breakthroughs, intriguing research, and some major governmental developments that could be good news for the future of the industry!

First, though, it's free webinar week at The Future of Protein Production, so don't forget to sign up to this Wednesday's 'Unleashing the Nutritional Potential of Plant-Based Proteins', with guest speakers from Huel, Nutrition Integration and Ingredion. To join the discussion, sign up here...

Onto news, after months of speculation and industry concern, Italy has now officially withdrawn its Technical Regulation Information System notification, aimed to block the production of cultivated meat and animal feed in the country. Experts, though, suggest the withdrawal is a strategic move to avoid the EC rejecting the bill outright.

Elsewhere, researchers at Harvard have estimated that eating red meat could double your risk of diabetes. In fact, participants who ate the most red meat had a 62% higher risk of developing type 2 diabetes compared to those who ate the least. Italy's Minister of Agriculture Francesco Lollobrigida should take note!

As far as breakthroughs go, an Austrian company has presented the first plant-based cheese alternative made from rescued fruit seeds, now available Billa Plus stores across the country, while on the other side of the planet, an Australian company has unveiled a fat that cooks, smells and tastes just like traditional meat.

Meanwhile, a French food-tech has announced a major investment round of US$34.7 million to drive innovation plant-based chicken innovation and US growth.

Read on to find out more…

Subscribe to keep reading

This content is free, but you must be subscribed to Protein Production Technology News to continue reading.

Already a subscriber?Sign In.Not now